- Board
strengthened through appointment of independent directors
- Additional
talent rounds up management team as preparations for planned uplisting
escalate
- Pursuit
of over 20 cannabis licenses from California Bureau of Cannabis Control
continues
- NUGS
plans to develop 250,000 square feet of cultivation space
Cannabis Strategic Ventures Inc. (OTC: NUGS) recently added
a number of cannabis industry insiders to its executive team and board of
directors. In October 2018, the company announced the appointment of Alan Tran
to its board of directors. Tran brings strong financial and strategic skills to
Cannabis Strategic Ventures, having led several successful management,
consulting and financial teams, not only within the cannabis, health care and
technology market sectors, but also within leading Fortune 500 companies. More
recently, NUGS has declared its intention to add two independent directors to
the board. This is a precursor to its planned uplisting to the OTCQB Venture
Market. The company also intends to add additional brands and assets to its
portfolio.
“The following board of director and team appointments
reflect the growth we’ve experienced as a company and our commitment to
positioning Cannabis Strategic Ventures as a leader in the cannabis industry,”
Simon Yu, CEO of Cannabis Strategic Ventures, noted in a news release. “As we
begin the uplisting process and take advantage of increasingly favorable cannabis
legislation worldwide, having a leading team in place will allow us to quickly
scale and address industry demands.”
The board of directors was strengthened through the
appointments of Tad Mailander and Jesus Quintero (http://ibn.fm/Vqqjx). Mailander,
who is currently a director of American Cannabis Company, is an attorney with
experience in handling SEC-related matters. Jesus Quintero is presently CFO of
MassRoots, a leading technology platform for the cannabis industry. Quintero
previously served as CFO of Brazil Interactive Media. He has a wealth of
experience in public company reporting. Accounting scandals in the 2000s have
caused Congress and a variety of regulatory bodies to strengthen governance
requirements – including the appointment of independent directors – for public
companies.
NUGS’ executive suite will also see two new faces. The
company has named Chris Young as its chief strategy officer. Young, who is
currently a board member, is an accomplished entertainment lawyer, fashion
entrepreneur and venture capital investor. Arlene Guzman will become vice
president of communications and operations. Guzman previously worked at Vantage
Point Capital Partners, a firm with more than $4.5 billion in capital under
management. She brings over 15 years’ experience as a communications and
operations professional in the venture capital and government spaces.
Cannabis Strategic Ventures expects its planned uplisting to
provide readier access to capital, as well as increasing the market and
liquidity of the company’s securities. Recently, the company finalized the
audit of its fiscal year ended March 31, 2018, marking the last of three audits
required by the U.S. Securities & Exchange Commission (SEC) as a condition
of becoming a fully reporting company.
The company has been executing a number of initiatives over
the past few months. Earlier in December, it announced its pursuit of over 20
cannabis licenses from the California Bureau of Cannabis Control, which it expects
will lead to the development of a substantial cannabis growth operation of
approximately 250,000 square feet of turnkey greenhouse space. NUGS will
commence cultivating as soon as licenses are issued (http://ibn.fm/iVdJl).
In November, details of a deal with Biolog Inc. were
announced. NUGS and Biolog, a portfolio client, will embark on a program to
develop water-soluble cannabis technologies for use in cannabis- and
phytocannabinoid-rich infused foods, beverages and consumer products.
In July, NUGS signed an agreement with Sunniva Inc. (CSE:
SNN) (OTCQX: SNNVF), under which a Sunniva subsidiary, CP Logistics, LLC
(“CPL”), will provide cannabis concentrate extraction services to Pure Applied
Sciences, Inc. (“PAS”), a wholly-owned subsidiary of Cannabis Strategic
Ventures. CPL will perform white label services, producing high quality,
ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral
City, California, for PAS under the “Pure Organix” brand – a brand that
was recently acquired by Cannabis Strategic Ventures. The agreement is for a
12-month term and may be renewed for an additional 12 months at the request of
PAS at the expiry of the initial term (http://ibn.fm/cBH56).
For more information, visit the company’s website at www.CannabisStrategic.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment